Summit Global Investments’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-49,812
Closed -$2.59M – 495
2021
Q4
$2.59M Buy
+49,812
New +$2.57M 0.17% 120
2021
Q3
– Sell
-21,554
Closed -$1.34M – 492
2021
Q2
$1.34M Buy
+21,554
New +$1.44M 0.08% 183

Other funds holding EHC

Summit Global Investments's EHC Position: Q1 2022 in Review

Summit Global Investments sold out of Encompass Health (EHC) in Q1 2022, closing a stake of 49,812 shares — an estimated $2.59M sold.

Summit Global Investments first reported a position in EHC in Q2 2021 and held it in 2 quarters. The position peaked at $2.59M in Q4 2021. 406 funds tracked by Wall St. Rank hold EHC as of Q1 2022.

  • Summit Global Investments reported no remaining Encompass Health position as of Q1 2022 after selling out during the quarter.
  • Summit Global Investments sold 49,812 Encompass Health shares in Q1 2022, an estimated $2.59M.
  • Summit Global Investments first reported a position in Encompass Health in Q2 2021 and held it in 2 quarters.
  • Summit Global Investments's Encompass Health position peaked at $2.59M in Q4 2021.
  • 406 funds tracked by Wall St. Rank held Encompass Health as of Q1 2022.

Based on Summit Global Investments's 13F filing for Q1 2022, filed 29 Apr 2022.